Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II - Concepedia

Concepedia

Publication | Open Access

Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II

DOI Full Paper Access

69

Citations

34

References

2008

Year

Lisa M. Oppegard, Andrei V. Ougolkov, Doris N. Luchini, Renee A. Schoon, John R. Goodell, Harneet Kaur, Daniel D. Billadeau, David M. Ferguson, Hiroshi Hiasa

European Journal of Pharmacology

Medicinal ChemistryPancreatic CancerBiochemistryNovel Acridine-based CompoundsMedicineNatural SciencesAnti-pancreatic Cancer ActivityHuman Topoisomerase IiAnti-cancer AgentPharmacologyCancer ResearchDrug Discovery

References

	Year	Citations

Page 1

Page 1